This result is consistent with a study result in which NAFLD and non-alcoholic steatohepatitis (NASH) patients with high insulin levels have significantly higher serum glutamate levels than healthy subjects (Kalhan et al., 2011). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.